Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 18301 - 18325 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	FOSL1	8061	upregulated	[Organoselenium Compounds binds to Copper] which results in increased expression of FOSL1 mRNA	11q13.1	A21751
Copper	Approved Investigational	FOXA2	3170	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FOXA2 mRNA	20p11.21	A21749
Copper	Approved Investigational	FOXA3	3171	downregulated	[Disulfiram binds to Copper] which results in decreased expression of FOXA3 mRNA	19q13.32	A21750
Copper	Approved Investigational	FOXJ1	2302	downregulated	[Disulfiram binds to Copper] which results in decreased expression of FOXJ1 mRNA	17q25.1	A21750
Copper	Approved Investigational	FOXM1	2305	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FOXM1 mRNA	12p13.33	A21749
Copper	Approved Investigational	FOXP2	93986	upregulated	[NSC 689534 binds to Copper] which results in increased expression of FOXP2 mRNA	7q31.1	A21749
Copper	Approved Investigational	FOXRED1	55572	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FOXRED1 mRNA	11q24.2	A21749
Copper	Approved Investigational	FOXRED2	80020	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FOXRED2 mRNA	22q12.3	A21749
Copper	Approved Investigational	FRAT1	10023	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FRAT1 mRNA	10q24.1	A21749
Copper	Approved Investigational	FRG1	2483	downregulated	[Disulfiram binds to Copper] which results in decreased expression of FRG1 mRNA	4q35.2	A21750
Copper	Approved Investigational	FRMD6	122786	upregulated	[NSC 689534 binds to Copper] which results in increased expression of FRMD6 mRNA	14q22.1	A21749
Copper	Approved Investigational	FRY	10129	upregulated	[NSC 689534 binds to Copper] which results in increased expression of FRY mRNA	13q13.1	A21749
Copper	Approved Investigational	FSIP1	161835	upregulated	[NSC 689534 binds to Copper] which results in increased expression of FSIP1 mRNA	15q14	A21749
Copper	Approved Investigational	FST	10468	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FST mRNA	5q11.2	A21749
Copper	Approved Investigational	FSTL1	11167	upregulated	[Disulfiram binds to Copper] which results in increased expression of FSTL1 mRNA	3q13.33	A21750
Copper	Approved Investigational	FTCD	10841	downregulated	[Disulfiram binds to Copper] which results in decreased expression of FTCD mRNA	21q22.3	A21750
Copper	Approved Investigational	FTH1	2495	upregulated	[NSC 689534 binds to Copper] which results in increased expression of FTH1 mRNA	11q12.3	A21749
Copper	Approved Investigational	FTH1P20	729009	downregulated	[Disulfiram binds to Copper] which results in decreased expression of FTH1P20 mRNA	2q31.3	A21750
Copper	Approved Investigational	FTL	2512	upregulated	[NSC 689534 binds to Copper] which results in increased expression of FTL mRNA	19q13.33	A21749
Copper	Approved Investigational	FUS	2521	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FUS mRNA	16p11.2	A21749
Copper	Approved Investigational	FYN	2534	upregulated	[NSC 689534 binds to Copper] which results in increased expression of FYN mRNA	6q21	A21749
Copper	Approved Investigational	FZD4	8322	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of FZD4 mRNA	11q14.2	A21749
Copper	Approved Investigational	G6PC	2538	downregulated	Copper results in decreased expression of G6PC mRNA	17q21.31	A21753
Copper	Approved Investigational	G6PD	2539	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of G6PD mRNA	Xq28	A21749
Copper	Approved Investigational	GABARAPL1	23710	upregulated	[NSC 689534 binds to Copper] which results in increased expression of GABARAPL1 mRNA	12p13.2	A21749

Displaying entries 18301 - 18325 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability